Authors: NISHIKIBE M ISHIKAWA K FUKURODA T OHTA H KANOH T OZAKI S NOGUCHI K SAITO M UEHARA S WILLIAMS D KIVLIGHN S KRAUSE S GABEL R ZINGARO G NOLAN N OBRIEN J CLAYTON F LYNCH J PETTIBONE D SIEGL P

Citation: M. Nishikibe et al., PHARMACOLOGY OF J-104,132, A POTENT, ORALLY-ACTIVE, MIXED ETA ETB ENDOTHELIN RECEPTOR ANTAGONIST/, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 5216-5216

Authors: GABEL R ZINGARO G NISHIKIBE M KIVLIGHN S SIEGL P

Citation: R. Gabel et al., ANTIHYPERTENSIVE EFFICACY OF J-104,132 (L753,037), A POTENT, ORALLY-ACTIVE, MIXED ETA ETB ENDOTHELIN RECEPTOR ANTAGONIST, IN CONSCIOUS, DOCA/SALT HYPERTENSIVE RATS/, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 3820-3820

Authors: STEPHENS J GABEL R HONCE J MOON J KETTERING J

Citation: J. Stephens et al., MICROBIAL LEAKAGE IN EXAMINATION GLOVES SUBJECTED TO ASTM WATER LEAKAGE TESTING, Journal of dental research, 77, 1998, pp. 1786-1786

Authors: KIVLIGHN SD GABEL R WILLIAMS DL WALSH TF GREENLEE WJ SIEGL PKS

Citation: Sd. Kivlighn et al., A POSSIBLE ROLE FOR THE ENDOTHELIN-B (ET(B)) RECEPTOR IN ACUTE CYCLOSPORINE-A (CSA) INDUCED NEPHROTOXICITY, Journal of the American Society of Nephrology, 6(3), 1995, pp. 999-999